期刊
FRONTIERS IN CHEMISTRY
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2021.746646
关键词
serum albumin-based nanovehicles; drug loading; diagnostic nanoprobes; cancer therapy; theranostics
资金
- National Natural Science Foundation of China [81671821, U19A2006, 11772088, 11972111, 31900940, 32071304]
- Sichuan Science and Technology Program [21YJ0130]
- China Postdoctoral Science Foundation [2019T120831, ZYGX2021YGLH017, ZYGX2021YGLH010, ZYGX2021YGLH023]
Nanovehicles based on serum albumin have gained significant attention in the field of cancer treatment, thanks to their biocompatibility, stability, ease of preparation, and multifunctionality. These nanovehicles show great potential in cancer diagnosis and therapy, offering various strategies and types for drug delivery and treatment of the disease.
Recently, drug delivery vehicles based on nanotechnology have significantly attracted the attention of researchers in the field of nanomedicine since they can achieve ideal drug release and biodistribution. Among the various organic or inorganic materials that used to prepare drug delivery vehicles for effective cancer treatment, serum albumin-based nanovehicles have been widely developed and investigated due to their prominent superiorities, including good biocompatibility, high stability, nontoxicity, non-immunogenicity, easy preparation, and functionalization, allowing them to be promising candidates for cancer diagnosis and therapy. This article reviews the recent advances on the applications of serum albumin-based nanovehicles in cancer diagnosis and therapy. We first introduce the essential information of bovine serum albumin (BSA) and human serum albumin (HSA), and discuss their drug loading strategies. We then discuss the different types of serum albumin-based nanovehicles including albumin nanoparticles, surface-functionalized albumin nanoparticles, and albumin nanocomplexes. Moreover, after briefly discussing the application of serum albumin-based nanovehicles used as the nanoprobes in cancer diagnosis, we also describe the serum albumin-based nanovehicle-assisted cancer theranostics, involving gas therapy, chemodynamic therapy (CDT), phototherapy (PTT/PDT), sonodynamic therapy (SDT), and other therapies as well as cancer imaging. Numerous studies cited in our review show that serum albumin-based nanovehicles possess a great potential in cancer diagnostic and therapeutic applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据